Drug Database
Back to search

Switzerland· 56215004

Arteoptic LA UD

A carteolol product containing carteololi hydrochloridum, registered in Switzerland and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 8 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat B (Swissmedic)ATC S01ED05

Checked against BAG Spezialitätenliste (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHBAG Spezialitätenliste (Switzerland)normalisedArteoptic LA UDATCS01ED05REGISTER NO.56215004PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about carteololi hydrochloridumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Carteolol is registered in 8 of 19 countries.

Countries holding a registration under ATC S01ED05 (carteolol), each read from that country’s own register.

  • This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
  • 6 of them publish a price we can compare per daily dose
Search carteolol products by name

Carteolol · ATC S01ED05

8 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Finlandprice
  • Netherlands
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

BAG Spezialitätenliste (Switzerland)
Active substance
carteololi hydrochloridum
Manufacturer
—
Country
Switzerland (CH)
ATC code
S01ED05
ATC class
Carteolol
Defined daily dose
0.2 ml, AT
Swissmedic category
B
Reimbursed
Yes
Source register
BAG Spezialitätenliste (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680562150042
    30 Unidos 0.2 ml
    CHF 16.55

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

97 interactions on record for carteolol.

Graded by severity as the source publishes them — 28 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check carteolol against other medicinesHow interaction checks work

Carteolol · interactions on record

97 records

  • 28 severe
  • 67 moderate
  • 2 minor

Most severe, free to view

  • EpinephrineB02BC09severe
  • EpinephrineC01CA24severe
  • OrciprenalinC01CA29severe
  • TheophyllinC01EB28severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Carteolol in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All carteolol products

Authorised across Europe · EMA

The same active substance is authorised in 12 EEA countries. Names it is sold under:

  • Belgium · Arteoptic La, Arteoptic La Sine Conservans
  • Czechia · Carteol Lp, Carteol Neo
  • Spain · Arteoptic, Arteoptic Pf
  • France · Carteol, Carteol L.P.
  • Croatia · Cartelomb
  • Italy · Carteabak, Carteol
  • Luxembourg · Arteoptic La, Arteoptic La Sine Conservans
  • Netherlands · Arteoptic Zonder Conserveermiddel, Carteabak
  • Poland · Carteol Lp, Carteol Lp Preservative Free
  • Portugal · Physioglau, Physioglau Pf
  • Slovenia · Cartelomb
  • Slovakia · Carteol Lp, Carteol Neo

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b98bd2f1-e063-4215-9065-74c1d292479b
GET /v1/drugs/b98bd2f1-e063-4215-9065-74c1d292479b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "carteololi hydrochloridum 20 mg",
  "valid_from": "2003-12-01",
  "limitations": null,
  "galenic_form": "Gtt Opht 2 %",
  "therapeutic_area": null,
  "sl_inclusion_date": "2003-12-01",
  "self_retention_pct": 10
}
API referenceMCP serverPlans

See everything about carteolol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console